These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8608648)

  • 1. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.
    Ruuls SR; Van Der Linden S; Sontrop K; Huitinga I; Dijkstra CD
    Clin Exp Immunol; 1996 Mar; 103(3):467-74. PubMed ID: 8608648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease.
    O'Brien NC; Charlton B; Cowden WB; Willenborg DO
    J Immunol; 2001 Nov; 167(10):5904-12. PubMed ID: 11698467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis.
    Zielasek J; Jung S; Gold R; Liew FY; Toyka KV; Hartung HP
    J Neuroimmunol; 1995 Apr; 58(1):81-8. PubMed ID: 7537283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long term NOS inhibition on disease and the immune system in MOG induced EAE.
    Danilov AI; Jagodic M; Wiklund NP; Olsson T; Brundin L
    Nitric Oxide; 2005 Nov; 13(3):188-95. PubMed ID: 16102987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis.
    Scott GS; Williams KI; Bolton C
    Inflamm Res; 1996 Oct; 45(10):524-9. PubMed ID: 8912019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase.
    Okuda Y; Sakoda S; Fujimura H; Yanagihara T
    J Neuroimmunol; 1998 Jan; 81(1-2):201-10. PubMed ID: 9521623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP; Schroder K; Powell HC; Kelly CJ
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction.
    O'Brien NC; Charlton B; Cowden WB; Willenborg DO
    J Immunol; 1999 Dec; 163(12):6841-7. PubMed ID: 10586085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
    Hasarmeh M; Itzik A; Weidenfeld J; Ovadia H
    Neuroimmunomodulation; 2016; 23(1):1-7. PubMed ID: 26670748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive nitric oxide production by rat alveolar macrophages.
    Miles PR; Bowman L; Rengasamy A; Huffman L
    Am J Physiol; 1998 Mar; 274(3):L360-8. PubMed ID: 9530171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation.
    Staykova MA; Cowden W; Willenborg DO
    Immunol Cell Biol; 2002 Apr; 80(2):188-97. PubMed ID: 11940120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution.
    Pozza M; Bettelli C; Aloe L; Giardino L; Calzà L
    Brain Res; 2000 Feb; 855(1):39-46. PubMed ID: 10650128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitation of nitric oxide production: cells from lymph node and spleen exhibit distinct difference in nitric oxide production.
    Xu L; Yang J; Huang Y; van der Meide PH; Levi M; Wahren B; Link H; Xiao B
    Immunol Lett; 2000 Mar; 71(3):177-84. PubMed ID: 10722870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin.
    Stanislaus R; Pahan K; Singh AK; Singh I
    Neurosci Lett; 1999 Jul; 269(2):71-4. PubMed ID: 10430507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of neuronal nitric oxide synthase in astrocytes and macrophages in the spinal cord of Lewis rats with autoimmune encephalomyelitis.
    Shin T
    J Vet Sci; 2001 Dec; 2(3):195-9. PubMed ID: 12441688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
    van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
    J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-arginine modifies free radical production and the development of experimental allergic encephalomyelitis.
    Scott GS; Bolton C
    Inflamm Res; 2000 Dec; 49(12):720-6. PubMed ID: 11211924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
    Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
    Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats.
    Huitinga I; Damoiseaux JG; Döpp EA; Dijkstra CD
    Eur J Immunol; 1993 Mar; 23(3):709-15. PubMed ID: 8449218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism.
    Hoey S; Grabowski PS; Ralston SH; Forrester JV; Liversidge J
    J Immunol; 1997 Nov; 159(10):5132-42. PubMed ID: 9366443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.